Zhang Donghong, Sun Xiaoli, Liu Jianlan, Xie Xina, Cui Wei, Zhu Yi
From the Department of Clinical Laboratory, Peking Union Medical College and Peking Union Medical College Hospital, Beijing, China (D.Z., W.C.); Department of Physiology and Pathophysiology, Key Laboratory of Cardiovascular Science of Ministry of Education, Peking University Health Science Center, Beijing, China (W.C.); Cardiovascular Research Center, Shantou University Medical College, Shantou, Guangdong, China (D.Z., J.L., X.X.); and Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China (Y.Z.).
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):71-8. doi: 10.1161/ATVBAHA.114.303899. Epub 2014 Oct 30.
Homocysteine can accelerate the senescence of endothelial progenitor cells or endothelial cells (ECs) via telomerase inactivation and length shortening. However, the underlying mechanism is unclear. Here, we investigated whether homocysteine promotes endothelial senescence by reducing the expression and activity of human telomerase reverse transcriptase (hTERT) by DNA methylation to reduce ECs telomerase activity.
When compared with primary human umbilical vein endothelial cells grown under standard conditions, ECs with chronic homocysteine treatment showed accelerated upregulation of p16, p21, and p53, markers of cellular senescence, during 6 to 10 passages. Interestingly, homocysteine-stimulated but not angiotensin II-stimulated ECs senescence could be reversed by hypermethylation induced by folic acid or s-adenosylmethionine supplementation. Meanwhile, homocysteine promoted the shortening of telomere length specifically related to restoration of hTERT transcriptional expression and CCCTC-binding factor binding sites with hTERT promoter hypomethylation, as detected by quantitative real-time polymerase chain reaction, Western blot, methylation-specific polymerase chain reaction, and bisulfite sequencing assay. Electrophoretic mobility shift assay and chromatin immunoprecipitation results showed that homocysteine-reduced telomere activity and homocysteine-induced EC senescence might contribute to hTERT promoter demethylation by increasing CCCTC-binding factor repression and interfering in the SP1 binding to the demethylated hTERT promoter, which might relate with reduced of DNA methyltransferase 1. Furthermore, the CCCTC-binding factor-dependent mechanism of homocysteine-reduced hTERT expression via DNA demethylation was confirmed in aortic endothelia of mice with hyperhomocysteine levels.
CCCTC-binding factor and SP1 cross talk may contribute to homocysteine-reduced hTERT DNA methylation and expression in endothelial senescence.
同型半胱氨酸可通过端粒酶失活和长度缩短加速内皮祖细胞或内皮细胞(ECs)衰老。然而,其潜在机制尚不清楚。在此,我们研究同型半胱氨酸是否通过DNA甲基化降低人端粒酶逆转录酶(hTERT)的表达和活性,从而降低ECs端粒酶活性,进而促进内皮细胞衰老。
与在标准条件下培养的原代人脐静脉内皮细胞相比,经慢性同型半胱氨酸处理的ECs在6至10代培养过程中,细胞衰老标志物p16、p21和p53的上调加速。有趣的是,叶酸或S-腺苷甲硫氨酸补充诱导的高甲基化可逆转同型半胱氨酸刺激而非血管紧张素II刺激的ECs衰老。同时,通过定量实时聚合酶链反应、蛋白质免疫印迹、甲基化特异性聚合酶链反应和亚硫酸氢盐测序分析检测发现,同型半胱氨酸促进了与hTERT转录表达恢复及hTERT启动子低甲基化相关的CCCTC结合因子结合位点的端粒长度缩短。电泳迁移率变动分析和染色质免疫沉淀结果表明,同型半胱氨酸降低端粒活性和诱导ECs衰老可能是通过增加CCCTC结合因子抑制并干扰SP1与去甲基化的hTERT启动子结合,导致DNA甲基转移酶1减少,进而促进hTERT启动子去甲基化。此外,在高同型半胱氨酸水平小鼠的主动脉内皮中证实了同型半胱氨酸通过DNA去甲基化降低hTERT表达的CCCTC结合因子依赖性机制。
CCCTC结合因子和SP1的相互作用可能导致同型半胱氨酸降低内皮细胞衰老过程中hTERT的DNA甲基化和表达。